Virbac Group
VIRP:FP FR0000031577
Key Information
HQ:
France
Market Cap:
$4.08bn
Primary Market:
Europe & Russia
Animal Pharmaceuticals Engagement
Analysis Breakdown
Sales and Marketing Practices
Strategy, risk and reporting on antibiotics
NRD
Applying a consistent sales and marketing approach in line with best practice operating market
Low
Manufacturing and Production
Demonstrating effective management of antibiotic residues in manufacturing and production
Low
Research and Development
Defining alternatives to antibiotics
Low
Increasing availability and use of alternatives to antibiotics
Low
Stakeholder Engagement and Lobbying
Stewardship initiatives
NRD
Lobbying and political expenditure
NRD
Company Engagement
Level of company engagement with the coalition
Least Engaged
Workstream Information
Last Updated:
22nd May 2023
2022/23 Resources
Virbac Group Assessment
Investor Briefing Pack
Sample Engagement Letter
Key Findings Report
Progress Report
Engagement Progress Report Webinar Video
Animal Pharmaceuticals Engagement